Menin-MLL
Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.
Products Related to Menin-MLL(5)
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10388 | MI-2 (hydrochloride) | - | >98% | |
menin-MLL interaction inhibitor | ||||
| GC11418 | MI-2 | 1271738-62-5 | >99.00% | |
An inhibitor of menin-MLL fusion protein interactions | ||||
| GC11837 | MI-136 | 1628316-74-4 | >98.50% | |
menin-MLL interaction inhibitor | ||||
| GC12173 | MI-nc (hydrochloride) | 1934302-23-4 | >98% | |
weak inhibitor of menin-MLL interaction | ||||
| GC12199 | MI-3 | 1271738-59-0 | >98.00% | |
An inhibitor of menin-MLL fusion protein interactions | ||||